The Claim
Whole-body MRI detects bone marrow infiltration and focal lesions in patients with multiple myeloma and high-risk smoldering myeloma more frequently than FDG-PET/CT, particularly in cases exhibiting diffuse or micronodular patterns, and this increased detection rate may influence clinical decision-making.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
A full-body MRI scan is better at spotting early signs of bone marrow cancer in certain types of myeloma than the PET/CT scan, especially when the cancer looks spread out in tiny spots — and this might change how doctors decide to treat patients.
See the scientific wording
Whole-body MRI detects bone marrow infiltration and focal lesions in multiple myeloma and high-risk smoldering myeloma more frequently than FDG-PET/CT, particularly in cases with diffuse or micronodular patterns, which may influence clinical decision-making.
What the research says
1 studyThe study found that whole-body MRI is better than PET/CT at spotting early or subtle bone marrow damage in myeloma patients, especially when the damage is spread out or tiny, and this helped doctors make better treatment choices.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.